BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29772432)

  • 21. Pre-administration of BAX-inhibiting peptides decrease the loss of the nigral dopaminergic neurons in rats.
    Ma C; Pan Y; Yang Z; Meng Z; Sun R; Wang T; Fei Y; Fan W
    Life Sci; 2016 Jan; 144():113-20. PubMed ID: 26612350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salidroside Protection Against Oxidative Stress Injury Through the Wnt/β-Catenin Signaling Pathway in Rats with Parkinson's Disease.
    Wu DM; Han XR; Wen X; Wang S; Fan SH; Zhuang J; Wang YJ; Zhang ZF; Li MQ; Hu B; Shan Q; Sun CH; Lu J; Zheng YL
    Cell Physiol Biochem; 2018; 46(5):1793-1806. PubMed ID: 29705802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotection by crocetin in a hemi-parkinsonian rat model.
    Ahmad AS; Ansari MA; Ahmad M; Saleem S; Yousuf S; Hoda MN; Islam F
    Pharmacol Biochem Behav; 2005 Aug; 81(4):805-13. PubMed ID: 16005057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6-OHDA induced calcium influx through N-type calcium channel alters membrane properties via PKA pathway in substantia nigra pars compacta dopaminergic neurons.
    Qu L; Wang Y; Zhang HT; Li N; Wang Q; Yang Q; Gao GD; Wang XL
    Neurosci Lett; 2014 Jul; 575():1-6. PubMed ID: 24861516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcγR I and TLR4 pathways.
    Zhang J; Niu N; Wang M; McNutt MA; Zhang D; Zhang B; Lu S; Liu Y; Liu Z
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1911-20. PubMed ID: 23791745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-Term Treatment with Silymarin Improved 6-OHDA-Induced Catalepsy and Motor Imbalance in Hemi-Parkisonian Rats.
    Haddadi R; Eyvari Brooshghalan S; Farajniya S; Mohajjel Nayebi A; Sharifi H
    Adv Pharm Bull; 2015 Nov; 5(4):463-9. PubMed ID: 26819917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of toll-like receptor 4 and sex in 6-hydroxydopamine-induced behavioral impairments and neurodegeneration in mice.
    Somensi N; Lopes SC; Gasparotto J; Mayer Gonçalves R; Tiefensee-Ribeiro C; Oppermann Peixoto D; Ozorio Brum P; Pinho CM; Agnes JP; Santos L; de Oliveira J; Spiller F; Fonseca Moreira JC; Zanotto-Filho A; Prediger RD; Pens Gelain D
    Neurochem Int; 2021 Dec; 151():105215. PubMed ID: 34710535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-Hydroxydopamine-lesioning of the nigrostriatal pathway in rats alters basal ganglia mRNA for copper, zinc- and manganese-superoxide dismutase, but not glutathione peroxidase.
    Kunikowska G; Jenner P
    Brain Res; 2001 Dec; 922(1):51-64. PubMed ID: 11730701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson's Disease Model.
    Chi H; Guan Y; Li F; Chen Z
    Cell Transplant; 2019 Dec; 28(1_suppl):87S-99S. PubMed ID: 31775521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson's disease.
    Crocker SJ; Wigle N; Liston P; Thompson CS; Lee CJ; Xu D; Roy S; Nicholson DW; Park DS; MacKenzie A; Korneluk RG; Robertson GS
    Eur J Neurosci; 2001 Jul; 14(2):391-400. PubMed ID: 11553289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress.
    Baluchnejadmojarad T; Mansouri M; Ghalami J; Mokhtari Z; Roghani M
    Biomed Pharmacother; 2017 Apr; 88():754-761. PubMed ID: 28157651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.
    Pan X; Chen C; Huang J; Wei H; Fan Q
    Neurosci Lett; 2015 Jul; 600():220-5. PubMed ID: 26101828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Melatonin Levels on Neurotoxicity of the Medial Prefrontal Cortex in a Rat Model of Parkinson's Disease.
    Li Y; Wang SM; Guo L; Zhu J; Wang Y; Li L; Zhao YX
    Chin Med J (Engl); 2017 Nov; 130(22):2726-2731. PubMed ID: 29133763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol delays 6-hydroxydopamine-induced apoptosis by activating the PI3K/Akt signaling pathway.
    Huang N; Zhang Y; Chen M; Jin H; Nie J; Luo Y; Zhou S; Shi J; Jin F
    Exp Gerontol; 2019 Sep; 124():110653. PubMed ID: 31295526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post treatment with Gastrodin suppresses oxidative stress and attenuates motor disorders following 6-OHDA induced Parkinson disease.
    Sadeghian Z; Eyvari-Brooshghalan S; Sabahi M; Nourouzi N; Haddadi R
    Neurosci Lett; 2022 Nov; 790():136884. PubMed ID: 36162540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA.
    Lorenc-Koci E; Czarnecka A; Lenda T; Kamińska K; Konieczny J
    Neurochem Int; 2013 Dec; 63(8):790-804. PubMed ID: 24090640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p-Hydroxybenzyl Alcohol Antagonized the ROS-Dependent JNK/Jun/Caspase-3 Pathway to Produce Neuroprotection in a Cellular Model of Parkinson's Disease.
    Lai MC; Liu WY; Liou SS; Liu IM
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of CDNF on 6-OHDA-induced apoptosis in PC12 cells via modulation of Bcl-2/Bax and caspase-3 activation.
    Mei JM; Niu CS
    Neurol Sci; 2014 Aug; 35(8):1275-80. PubMed ID: 24633814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.
    Gui ZH; Liu J; Wang Y; Ali U; Wang T; Chen L
    Chin J Physiol; 2011 Apr; 54(2):96-104. PubMed ID: 21789890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.